In this current study, GPR89A gene knockout by CRISPR‐Cas9 in combination with cisplatin exposure in CR‐Calu1 cells also caused a synergistic effect by increasing apoptotic cell death rates of NSCLC cells. Here, GPHRA is linked to non-small cell lung carcinoma.